• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质刚度影响在聚乙二醇化纤维蛋白原生物材料中培养的心肌细胞的自发收缩。

Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial.

作者信息

Shapira-Schweitzer Keren, Seliktar Dror

机构信息

Faculty of Biomedical Engineering, Technion - Israel Institute of Technology, Technion City, Haifa 32000, Israel.

出版信息

Acta Biomater. 2007 Jan;3(1):33-41. doi: 10.1016/j.actbio.2006.09.003. Epub 2006 Nov 13.

DOI:10.1016/j.actbio.2006.09.003
PMID:17098488
Abstract

Successful implementation of cardiac cell transplantation for treating damaged myocardium relies on the development of improved injectable biomaterials. A novel biomaterial technology using PEGylated fibrinogen has been developed with controllable physicochemical properties based on the poly(ethylene glycol) (PEG) constituent. In addition, the fibrinogen backbone of the material confers inherent bioactivity to cells. The purpose of this investigation was to explore by in vitro techniques the use of this biomaterial as a scaffold for cardiac tissue regeneration. To this end neonatal rat cardiomyocytes were cultivated in PEGylated fibrinogen constructs. The cell-seeding density and biomaterial composition were optimized to obtain maximum spontaneous contraction of the constructs. Quantitative characterization of the contraction pattern was accomplished by video image analysis. It was possible to demonstrate an inverse correlation between the material stiffness and the amplitude of contraction of the tissue constructs by changing the modulus of the matrix using different compositions of PEG and fibrinogen. The relationship between matrix stiffness, cell density and tissue contraction also provided some insight into the mechanism of cellular remodeling that ultimately leads to synchronized contraction of the constructs. These findings indicate that PEGylated fibrinogen hydrogels can be used as a scaffold for cardiomyocytes, and offer the possibility of controlling cellular remodeling via simple compositional modifications to the matrix.

摘要

成功实施用于治疗受损心肌的心脏细胞移植依赖于改进的可注射生物材料的开发。一种基于聚乙二醇(PEG)成分、具有可控物理化学性质的新型生物材料技术——聚乙二醇化纤维蛋白原已被开发出来。此外,该材料的纤维蛋白原主链赋予细胞内在生物活性。本研究的目的是通过体外技术探索这种生物材料作为心脏组织再生支架的用途。为此,将新生大鼠心肌细胞培养在聚乙二醇化纤维蛋白原构建体中。优化细胞接种密度和生物材料组成以获得构建体的最大自发收缩。通过视频图像分析对收缩模式进行定量表征。通过使用不同组成的PEG和纤维蛋白原改变基质模量,有可能证明材料硬度与组织构建体收缩幅度之间呈负相关。基质硬度、细胞密度与组织收缩之间的关系也为最终导致构建体同步收缩的细胞重塑机制提供了一些见解。这些发现表明,聚乙二醇化纤维蛋白原水凝胶可作为心肌细胞的支架,并通过对基质进行简单的成分修饰提供控制细胞重塑的可能性。

相似文献

1
Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial.基质刚度影响在聚乙二醇化纤维蛋白原生物材料中培养的心肌细胞的自发收缩。
Acta Biomater. 2007 Jan;3(1):33-41. doi: 10.1016/j.actbio.2006.09.003. Epub 2006 Nov 13.
2
The role of matrix metalloproteinases in regulating neuronal and nonneuronal cell invasion into PEGylated fibrinogen hydrogels.基质金属蛋白酶在调节神经元和非神经元细胞侵入聚乙二醇化纤维蛋白原水凝胶中的作用。
Biomaterials. 2010 Sep;31(25):6411-6. doi: 10.1016/j.biomaterials.2010.04.052.
3
The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration.聚乙二醇-纤维蛋白原水凝胶支架的结构改变对三维细胞形态和细胞迁移的影响。
Biomaterials. 2006 Mar;27(8):1496-506. doi: 10.1016/j.biomaterials.2005.09.038. Epub 2005 Oct 21.
4
A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model.一种用于大鼠模型胫骨节段性缺损修复的新型聚乙二醇-纤维蛋白原水凝胶。
J Biomed Mater Res A. 2007 Mar 15;80(4):874-84. doi: 10.1002/jbm.a.30928.
5
The influence of ascorbic acid, TGF-beta1, and cell-mediated remodeling on the bulk mechanical properties of 3-D PEG-fibrinogen constructs.抗坏血酸、转化生长因子-β1和细胞介导的重塑对三维聚乙二醇-纤维蛋白原构建体的整体力学性能的影响。
Biomaterials. 2009 Aug;30(23-24):3854-64. doi: 10.1016/j.biomaterials.2009.04.013. Epub 2009 May 13.
6
The biocompatibility of PluronicF127 fibrinogen-based hydrogels.基于纤维蛋白原的泊洛沙姆 F127 水凝胶的生物相容性。
Biomaterials. 2010 Apr;31(10):2836-47. doi: 10.1016/j.biomaterials.2009.12.050. Epub 2010 Jan 21.
7
Polymer-conjugated albumin and fibrinogen composite hydrogels as cell scaffolds designed for affinity-based drug delivery.聚合物偶联白蛋白和纤维蛋白原复合水凝胶作为基于亲和力的药物输送设计的细胞支架。
Acta Biomater. 2011 Jan;7(1):163-70. doi: 10.1016/j.actbio.2010.07.017. Epub 2010 Jul 17.
8
A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells.一种用于人胚胎干细胞衍生心肌细胞和大鼠新生心脏细胞三维培养的可光聚合水凝胶。
J Mol Cell Cardiol. 2009 Feb;46(2):213-24. doi: 10.1016/j.yjmcc.2008.10.018. Epub 2008 Nov 5.
9
Immobilized fibrinogen in PEG hydrogels does not improve chondrocyte-mediated matrix deposition in response to mechanical stimulation.聚乙二醇水凝胶中固定化的纤维蛋白原并不能改善软骨细胞介导的基质沉积对机械刺激的反应。
Biotechnol Bioeng. 2006 Dec 20;95(6):1061-9. doi: 10.1002/bit.21072.
10
Fabrication of PEGylated fibrinogen: a versatile injectable hydrogel biomaterial.聚乙二醇化纤维蛋白原的制备:一种多功能可注射水凝胶生物材料。
Methods Mol Biol. 2014;1181:61-8. doi: 10.1007/978-1-4939-1047-2_6.

引用本文的文献

1
Rapid Video Analysis for Contraction Synchrony of Human Induced Pluripotent Stem Cells-Derived Cardiac Tissues.用于人类诱导多能干细胞衍生心脏组织收缩同步性的快速视频分析
Tissue Eng Regen Med. 2025 Feb;22(2):211-224. doi: 10.1007/s13770-024-00688-4. Epub 2025 Jan 13.
2
Hydrogels in cardiac tissue engineering: application and challenges.心脏组织工程中的水凝胶:应用与挑战
Mol Cell Biochem. 2025 Apr;480(4):2201-2222. doi: 10.1007/s11010-024-05145-3. Epub 2024 Nov 4.
3
Mind the mechanical strength: tailoring a 3D matrix to encapsulate isolated human preantral follicles.
注意机械强度:定制3D基质以包裹分离的人窦前卵泡。
Hum Reprod Open. 2023 Feb 17;2023(2):hoad004. doi: 10.1093/hropen/hoad004. eCollection 2023.
4
Decellularization Strategies for Regenerating Cardiac and Skeletal Muscle Tissues.用于再生心脏和骨骼肌组织的去细胞化策略
Front Bioeng Biotechnol. 2022 Feb 28;10:831300. doi: 10.3389/fbioe.2022.831300. eCollection 2022.
5
Engineering the niche to differentiate and deploy cardiovascular cells.工程化龛位以分化和移植心血管细胞。
Curr Opin Biotechnol. 2022 Apr;74:122-128. doi: 10.1016/j.copbio.2021.11.003. Epub 2021 Nov 30.
6
Effects of electrically conductive nano-biomaterials on regulating cardiomyocyte behavior for cardiac repair and regeneration.导电纳米生物材料对调节心肌细胞行为以促进心脏修复和再生的影响。
Acta Biomater. 2022 Feb;139:141-156. doi: 10.1016/j.actbio.2021.11.022. Epub 2021 Nov 21.
7
Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery.利用人类干细胞衍生的心肌细胞进行心脏组织工程,用于疾病建模和药物发现。
Drug Discov Today Dis Models. 2012 Winter;9(4):e219-e227. doi: 10.1016/j.ddmod.2012.11.001. Epub 2012 Dec 21.
8
Methods to Model Cardiac Mechanobiology in Health and Disease.方法来模拟心脏力学在健康和疾病中的作用。
Tissue Eng Part C Methods. 2021 Mar;27(3):139-151. doi: 10.1089/ten.TEC.2020.0342. Epub 2021 Mar 5.
9
Fibrin-based Bioinks: New Tricks from an Old Dog.基于纤维蛋白的生物墨水:老方法的新应用
Int J Bioprint. 2020 Apr 29;6(3):269. doi: 10.18063/ijb.v6i3.269. eCollection 2020.
10
Spatiotemporally Controlled Photoresponsive Hydrogels: Design and Predictive Modeling from Processing through Application.时空可控的光响应水凝胶:从加工到应用的设计与预测建模
Adv Funct Mater. 2020 Aug 7;30(32):2000639. doi: 10.1002/adfm.202000639. Epub 2020 Jun 18.